QuidelOrtho Corp — Director's Dealing 2026

Feb 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: QuidelOrtho Corp (QDEL)
CIK: 0001906324
Period of Report: 2026-01-30

Reporting Person: Hodges Michelle A (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-31	Common Stock	A	1610	—	Acquired	38970	Direct
2026-01-31	Common Stock	F	578	$27.17	Disposed	38392	Direct
2026-01-31	Common Stock	A	1814	—	Acquired	40206	Direct
2026-01-31	Common Stock	F	651	$27.17	Disposed	39555	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-30	Restricted Stock Units	$	A	38562	Acquired		Common Stock (38562)	Direct
2026-01-30	Non-Qualified Stock Options	$27.17	A	38561	Acquired	2036-01-30	Common Stock (38561)	Direct
2026-01-31	Restricted Stock Units	$	M	1610	Disposed		Common Stock (1610)	Direct
2026-01-31	Restricted Stock Units	$	M	1814	Disposed		Common Stock (1814)	Direct

Footnotes

F1: Reflects release of restricted stock units that were previously reported on a Form 4.

F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

F4: 38,562 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.

F5: 12,853 shares will vest on January 30, 2027; the remaining 25,708 shares will vest in equal installments on January 30, 2028 and January 30, 2029.

F6: 1,610 shares vested on each of January 31, 2024, January 31, 2025 and January 31, 2026.

F7: 3,628 shares vested on January 31, 2024; and 1,814 shares vested on each of January 31, 2025 and January 31, 2026.